title: Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation.
abstract: It is not clear whether pretransplantation MELD (model for End-Stage Liver Disease) score can foresee posttransplant outcome. We retrospectively evaluated 80 adult patients (55 men, 25 women) who underwent living donor liver transplantation between September 1998 and March 2003. Five other patients with fulminant hepatitis were excluded. The UNOS-modified MELD scores were calculated to stratify patients into three groups: group 1) MELD score less than 15 (n = 13); group 2) MELD score 15 to 24 (n = 36); and group 3) MELD score 25 and higher (n = 26). The patients were predominantly men (n = 52, 69.3%) with overall mean age of 43.9 years (range, 17-62 years). The mean follow-up was 15.7 months (range, 1-47; median = 14 months). The mean MELD score was 22.7 (range, 9-50; median = 21). The overall 1- and 2-year patient survivals were 87% and 78.7%, respectively. The 1-year patient survivals for groups 1, 2, and 3 were 100%, 87%, and 79%; respectively. 2-year survivals, 100%, 79%, and 61%, respectively. Survivals stratified by MELD showed no statistically remarkable differences in 1-year and 2-year patient survival (P = .08). In contrast, 1-year and 2-year patient survival rates for UNOS status 2A, 2B, and 3 were 73%-50%, 95%-91%, and 91%-91%, statistically significant difference (P = .002). Finally, to date preoperative MELD score showed no significant impact on 1- and 2-year posttransplant outcomes in adult-to-adult living donor liver transplantation recipients, but we await longer-term follow-up with greater numbers of patients.
authors.affiliation: Edge University Medical School, Izmir, Turkey. akylidizmr@yahoo.com
authors.forename: M
authors.initials: M
authors.lastname: Akyildiz
authors.forename: Z
authors.initials: Z
authors.lastname: Karasu
authors.forename: C
authors.initials: C
authors.lastname: Arikan
authors.forename: M
authors.initials: M
authors.lastname: Kilic
authors.forename: M
authors.initials: M
authors.lastname: Zeytunlu
authors.forename: F
authors.initials: F
authors.lastname: Gunsar
authors.forename: G
authors.initials: G
authors.lastname: Ersoz
authors.forename: U
authors.initials: U
authors.lastname: Akarca
authors.forename: Y
authors.initials: Y
authors.lastname: Batur
authors.forename: Y
authors.initials: Y
authors.lastname: Tokat
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D017093:Liver Failure / Q000145:classification* / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology*; D019520:Living Donors; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome